At last week’s annual LabAutomation Conference, pharmacogenomics was a sizzling buzzword. It was also one of those areas where many attendees said they wanted to get into, but few professed to know much about.

Still, by the time the conference wound up last Wednesday, few attendees hung around to hear Chris Herold, of San Diego startup Prediction Sciences, discuss the pharmacogenomics technology he hopes will turn the world of blockbuster antidepressants on its head.

Those who left early might just regret not staying.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.